Bank of Montreal’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-543,200
| Closed | -$3.19M | – | 4435 |
|
|
2022
Q4 | $3.19M | Buy |
+543,200
| New | +$2.86M | ﹤0.01% | 1545 |
|
|
2021
Q3 | – | Sell |
-45,777
| Closed | -$201K | – | 4010 |
|
|
2021
Q2 | $201K | Buy |
45,777
+44,920
| +5,242% | +$190K | ﹤0.01% | 3213 |
|
|
2021
Q1 | $4K | Sell |
857
-3,739
| -81% | -$30.2K | ﹤0.01% | 4783 |
|
|
2020
Q4 | $57K | Buy |
4,596
+3,271
| +247% | +$37.3K | ﹤0.01% | 3884 |
|
|
2020
Q3 | $15K | Sell |
1,325
-967
| -42% | -$9.53K | ﹤0.01% | 3962 |
|
|
2020
Q2 | $23K | Buy |
+2,292
| New | +$22K | ﹤0.01% | 3796 |
|
|
2020
Q1 | – | Sell |
-2,697
| Closed | -$25K | – | 4904 |
|
|
2019
Q4 | $25K | Buy |
2,697
+807
| +43% | +$5.72K | ﹤0.01% | 4197 |
|
|
2019
Q3 | $11K | Buy |
1,890
+66
| +4% | +$700 | ﹤0.01% | 4391 |
|
|
2019
Q2 | $22K | Buy |
+1,824
| New | +$19.6K | ﹤0.01% | 4137 |
|
|
2019
Q1 | – | Sell |
-1,095
| Closed | -$14K | – | 4889 |
|
|
2018
Q4 | $14K | Buy |
1,095
+155
| +16% | +$2.14K | ﹤0.01% | 3778 |
|
|
2018
Q3 | $14K | Sell |
940
-1,904
| -67% | -$30K | ﹤0.01% | 3830 |
|
|
2018
Q2 | $48K | Buy |
2,844
+2,051
| +259% | +$39.8K | ﹤0.01% | 3423 |
|
|
2018
Q1 | $18K | Hold |
793
| – | – | ﹤0.01% | 3590 |
|
|
2017
Q4 | $21K | Hold |
793
| – | – | ﹤0.01% | 3577 |
|
|
2017
Q3 | $12K | Buy |
+793
| New | +$11.5K | ﹤0.01% | 3652 |
|
|
2017
Q1 | – | Sell |
-23,973
| Closed | -$217K | – | 4257 |
|
|
2016
Q4 | $217K | Buy |
+23,973
| New | +$219K | ﹤0.01% | 2457 |
|
|
2016
Q3 | – | Sell |
-1,616
| Closed | -$18K | – | 4248 |
|
|
2016
Q2 | $18K | Buy |
+1,616
| New | +$20.6K | ﹤0.01% | 3430 |
|
|
2015
Q4 | – | Sell |
-23,973
| Closed | -$450K | – | 4487 |
|
|
2015
Q3 | $450K | Buy |
+23,973
| New | +$407K | ﹤0.01% | 1905 |
|
|
2014
Q3 | – | Sell |
-160
| Closed | -$2K | – | 4509 |
|
|
2014
Q2 | $2K | Buy |
+160
| New | +$1.54K | ﹤0.01% | 4528 |
|
Bank of Montreal's CNCE Position: Q1 2023 in Review
Bank of Montreal sold out of Concert Pharmaceuticals, Inc. (CNCE) in Q1 2023, closing a stake of 543,200 shares — an estimated $3.19M sold.
Bank of Montreal first reported a position in CNCE in Q2 2014 and held it in 19 quarters. The position peaked at $3.19M in Q4 2022. 0 funds tracked by Wall St. Rank hold CNCE as of Q1 2023.
- Bank of Montreal reported no remaining Concert Pharmaceuticals, Inc. position as of Q1 2023 after selling out during the quarter.
- Bank of Montreal sold 543,200 Concert Pharmaceuticals, Inc. shares in Q1 2023, an estimated $3.19M.
- Bank of Montreal first reported a position in Concert Pharmaceuticals, Inc. in Q2 2014 and held it in 19 quarters.
- Bank of Montreal's Concert Pharmaceuticals, Inc. position peaked at $3.19M in Q4 2022.
- 0 funds tracked by Wall St. Rank held Concert Pharmaceuticals, Inc. as of Q1 2023.
Based on Bank of Montreal's 13F filing for Q1 2023, filed 13 Jun 2024.